We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$703M
AUM Growth
-$959K
Cap. Flow
-$27.3M
Cap. Flow %
-3.89%
Top 10 Hldgs %
67.63%
Holding
70
New
23
Increased
4
Reduced
11
Closed
1

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$2.77M
2
WAB icon
Wabtec
WAB
+$1.96M
3
DBVT
DBV Technologies
DBVT
+$1.02M
4
AMAG
AMAG Pharmaceuticals
AMAG
+$958K
5
GILD icon
Gilead Sciences
GILD
+$893K

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$13.5M
2
NOV icon
NOV
NOV
+$7.05M
3
PSX icon
Phillips 66
PSX
+$6.59M
4
DE icon
Deere & Co
DE
+$5.19M
5
XOM icon
ExxonMobil
XOM
+$2.51M

Sector Composition

Rank Sector Weight
1 Financials 40.44%
2 Healthcare 21.67%
3 Technology 15.98%
4 Industrials 9.65%
5 Energy 5.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGYP
51
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$699K 0.1%
+150,000
New +$870K
BIVV
52
DELISTED
Bioverativ Inc. Common Stock
BIVV
$599K 0.09%
+11,000
New +$542K
BDSI
53
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$503K 0.07%
+264,610
New +$510K
AUPH icon
54
Aurinia Pharmaceuticals
AUPH
$2.04B
$440K 0.06%
+60,000
New +$277K
RNAC icon
55
Cartesian Therapeutics
RNAC
$260M
$349K 0.05%
+812
New +$342K
SYNT
56
DELISTED
Syntel Inc
SYNT
$332K 0.05%
+19,700
New +$382K
OCRX
57
DELISTED
Ocera Therapeutics, Inc.
OCRX
$328K 0.05%
+250,000
New +$318K
DVAX
58
DELISTED
Dynavax Technologies
DVAX
$298K 0.04%
+50,000
New +$240K
ANIP icon
59
ANI Pharmaceuticals
ANIP
$1.71B
$248K 0.04%
+5,000
New +$281K
ACOR
60
DELISTED
Acorda Therapeutics
ACOR
$210K 0.03%
+83
New +$239K
CNCE
61
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$200K 0.03%
+11,743
New +$141K
ALDX icon
62
Aldeyra Therapeutics
ALDX
$91.1M
$188K 0.03%
+37,662
New +$194K
CLDX icon
63
Celldex Therapeutics
CLDX
$3.48B
$181K 0.03%
+3,333
New +$174K
ABEO icon
64
Abeona Therapeutics
ABEO
$422M
$150K 0.02%
+1,200
New +$155K
LCTX icon
65
Lineage Cell Therapeutics
LCTX
$283M
$122K 0.02%
+40,318
New +$114K
PRQR icon
66
ProQR Therapeutics
PRQR
$271M
$121K 0.02%
+24,144
New +$106K
EIGR
67
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$118K 0.02%
+344
New +$118K
DE icon
68
Deere & Co
DE
$167B
– –
-50,400
Closed -$5.19M
1 2
3

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q1 2017 Portfolio in Review

As of Q1 2017, Hikari Power held 70 positions worth $703M, down 0.14% from $704M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Hikari Power withdrew a net $27.3M in Q1 2017, closing 1 position and reducing 11 holdings. Its most notable exit was Deere & Co, an estimated $5.19M position sold in full.

By sector, the portfolio is most concentrated in Financials at 40% of assets, down from 41% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Hikari Power opened a new position in Wabtec worth $1.85M.

  • Hikari Power's largest Q1 2017 buy was Wabtec: 23,700 shares worth $1.85M.
  • Hikari Power added most to Allergan plc in Q1 2017, an estimated $2.77M increase.
  • Hikari Power's biggest Q1 2017 reduction was Wells Fargo, cutting an estimated $13.5M.
  • Hikari Power fully exited Deere & Co in Q1 2017, selling an estimated $5.19M.
  • Hikari Power's ten largest holdings make up 68% of its $703M portfolio in Q1 2017.
  • Hikari Power opened 23 new positions and closed 1 in Q1 2017.
  • Hikari Power's portfolio value fell 0.14% quarter-over-quarter to $703M.

Based on Hikari Power's 13F filing for Q1 2017, filed 26 Apr 2017.